Using Managed Entry Agreements as an Effective Tool to Handle the Uncertainty in Health Technology Assessments
Although the access to innovative medicines is usually informed by health technology assessment reports, underlying uncertainties in HTA may delay such access. Managed Entry Agreements may provide a promising solution to handle such uncertainty through focusing on value for information. Notably, ma...
Main Authors: | Vatsal Chhaya, Kapil Khambholja |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2022-07-01
|
Series: | Health Technology Assessment in Action |
Subjects: | |
Online Access: | https://htainaction.tums.ac.ir/index.php/hta/article/view/110 |
Similar Items
-
Decision-making on listing new medicines for public funding in New Zealand: the case of 'new' type 2 diabetes medications
by: Caroline Stretton, et al.
Published: (2022-01-01) -
Efficiency of “Prescribe Vida Saludable”, a health promotion innovation. Pilot phase
by: Aitor Sanz-Guinea, et al.
Published: (2017-09-01) -
Health Technology Assessment Process for Oncology Drugs: Impact of CADTH Changes on Public Payer Reimbursement Recommendations
by: Louise Binder, et al.
Published: (2022-03-01) -
Health economics and health preference concepts to orthopedics practitioners
by: Carlos Delano Mundim Araújo, et al.
Published: (2014-01-01) -
ESTIMATING QALYS IN THE WESTERN REGION OF ROMANIA – THE CASE WITH INTERVENTION
by: Pantea Marius, et al.
Published: (2013-07-01)